This grant is for advancing translational and clinical research in pediatric and obstetric pharmacology and therapeutics. It encourages applications, including clinical trials, to enhance understanding of drug action, response, and safety in children, pregnant women, and developing fetuses. The core purpose is to improve the effectiveness and safety of current drugs, develop new ones, and promote safer use of existing medications for these special populations. The funding seeks to address emerging clinical needs by fostering research that leads to tailored therapies, ultimately improving health outcomes for pediatric and obstetric patients.
Opportunity ID: 239294
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-13-310 |
| Funding Opportunity Title: | Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R03) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health Income Security and Social Services |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.865 — Child Health and Human Development Extramural Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Aug 05, 2013 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Aug 16, 2016 |
| Current Closing Date for Applications: | Aug 16, 2016 |
| Archive Date: | Sep 16, 2016 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $50,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | For profit organizations other than small businesses County governments Special district governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Small businesses Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities State governments Independent school districts Private institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Native American tribal organizations (other than Federally recognized tribal governments) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this funding opportunity announcement (FOA) is to encourage applications for translational and clinical research as well as clinical trials that will advance our knowledge about the underlying mechanisms of drug action, response, and safety in children at various developmental stages, and in pregnant women and the developing fetus. The overall goals of the FOA are to improve the safety and effectiveness of current drugs for pediatric or obstetric patients, and to enhance the development of new drugs or a safer usage of the existing drugs for tailored therapies to meet emerging clinical needs for these special populations. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-13-310.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 93.865 | FORMS-C | Forms-C | PKG00182452 | Oct 19, 2013 | Jun 07, 2016 | View |
| FORMS-D | Use for due dates on or after May 25, 2016 | PKG00223981 | Jul 16, 2016 | Aug 16, 2016 | View |
Package 1
Mandatory forms
239294 RR_SF424_2_0-2.0.pdf
239294 PHS398_ResearchPlan_2_0-2.0.pdf
239294 PHS398_CoverPageSupplement_2_0-2.0.pdf
239294 RR_KeyPersonExpanded_2_0-2.0.pdf
239294 RR_OtherProjectInfo_1_3-1.3.pdf
239294 PerformanceSite_2_0-2.0.pdf
Optional forms
239294 RR_SubawardBudget30_1_3-1.3.pdf
239294 PlannedReport-1.0.pdf
239294 PHS398_CumulativeInclusionReport-1.0.pdf
239294 PHS398_ModularBudget_1_2-1.2.pdf
239294 RR_Budget_1_3-1.3.pdf
Package 2
Mandatory forms
239294 RR_SF424_2_0-2.0.pdf
239294 PHS398_CoverPageSupplement_3_0-3.0.pdf
239294 RR_OtherProjectInfo_1_3-1.3.pdf
239294 PerformanceSite_2_0-2.0.pdf
239294 RR_KeyPersonExpanded_2_0-2.0.pdf
239294 PHS398_ResearchPlan_3_0-3.0.pdf
Optional forms
239294 RR_Budget_1_3-1.3.pdf
239294 RR_SubawardBudget30_1_3-1.3.pdf
239294 PHS398_ModularBudget_1_2-1.2.pdf
239294 PHS_Inclusion_Enrollment_Report-1.0.pdf
239294 PHS_AssignmentRequestForm-1.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
